Mechanism of Diuretic Action
Osmotic diuretics differ fundamentally from other diuretic classes (such as furosemide, amiloride, spironolactone, or acetazolamide). Unlike them, the prototype agent of this class — mannitol (Mannitolum) — does not interact with epithelial enzymes or cellular receptors whatsoever. Its effect relies entirely on the laws of physics and chemistry.
The pharmacokinetics of the drug are extremely straightforward: it does not undergo metabolism. Following intravenous administration, the substance is freely filtered through the capillary endothelium of the renal glomeruli into the nephron lumen. The key feature of mannitol is that it does not undergo tubular reabsorption.
Moving along the entire length of the tubular apparatus, the molecules create and sustain a high osmotic pressure. They literally prevent reabsorption and retain water within the nephron lumen. This occurs in key zones of passive water reabsorption via aquaporins:
- Proximal convoluted tubules.
- Descending limb of the loop of Henle.
- Collecting ducts.
As a result, the physiological effect manifests as a significant increase in the volume of tubular fluid (urine). Meanwhile, sodium ion ($Na^+$) reabsorption decreases only secondarily and to a very minor extent.
Systemic Dehydrating Effect
The action of mannitol is not limited to the kidneys. Remaining in the systemic circulation, the drug increases blood plasma osmotic pressure. Because the molecules of this osmotically active substance poorly penetrate biological membranes, they cannot leave the vascular bed.
A powerful pressure gradient is established: fluid begins to shift from tissues into the blood vessels. This mechanism works especially effectively for the dehydration of structures reliably protected by blood-tissue barriers, since mannitol does not cross them. This primarily concerns the brain tissue and eyeballs.
Clinical Application
Due to its unique properties and rapid onset of action (excreted within 30–60 minutes), osmotic diuretics are used in emergency medicine. The main clinical indications include:
- Cerebral edema: utilizing the dehydrating capacity of the drug to rapidly remove excess fluid from CNS tissues.
- Acute glaucoma attack: for the emergency reduction of intraocular pressure via the osmotic gradient.
- Chemical poisonings: as part of forced diuresis procedures to maximally accelerate toxin elimination in the urine.
- Oliguria: in severe conditions associated with hemodynamic impairment (extensive burns, trauma, massive blood loss). The drug helps maintain glomerular filtration and prevent acute kidney injury.
Adverse Effects
The use of mannitol requires monitoring, as rapid changes in osmotic balance and fluid redistribution can lead to adverse reactions.
Among general symptoms, patients often report marked weakness and dry mouth. Cardiovascular side effects may include tachycardia. The most severe complications involve the central nervous system, carrying a risk of seizures.